Delivery Order SPE2DB22D2108-SPE2DB24FU4WT

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of dextroamphetamine extended-release 10 mg capsules in 90-count packages, with a total ceiling value of $2,457.09. The contract is a firm fixed-price delivery order, with an ultimate completion date of May 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,970,595 units of Dextroamphetamine Extended Release 15 mg capsules. The $1,135.04 firm fixed price award has a completion date of September 30, 2024 and was made on September 27, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of dextroamphetamine extended-release 10 mg capsules. The contract has a ceiling value of $1,329.34 and a completion date of June 26, 2025. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp is a...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,166,325 units of dextroamphetamine extended-release 15 mg capsules. The contract, valued at $3,735.04, has a completion date of July 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medications to support federal healthcare programs and services. This award is a part of a larger Indefinite Delivery Contract...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 90 capsules of 10 mg dextroamphetamine extended-release medication. The contract has a firm fixed price of $1,149.48 and a completion date of May 20, 2025. The award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $1,809.93 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,464,709 units of 15 mg dextroamphetamine extended-release capsules. The contract has a performance period through May 2, 2024. This delivery order is part of Amerisourcebergen's broader $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to provide a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,533,880 units of dextroamphetamine extended-release 10 mg capsules in 100-count bottles. The contract has a ceiling value of $4,123.42 and an ultimate completion date of March 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10mg dextroamphetamine sustained-release capsules. The contract has a firm fixed-price of $6,205.52 and a completion date of May 27, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The $2,045.01 firm-fixed-price delivery order is for the supply of 4,566,066,914 units of Dextroamphetamine Extended-Release 15mg Capsules in 100-count packages. The contract has an ultimate completion date of October 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,561,020,421 units of Dextroamphetamine Extended-Release 15 mg capsules. The $1,465.68 firm-fixed-price contract has a performance period through May 23, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB24FU4WT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of dextroamphetamine extended-release 15 mg capsules in 100-count bottles. The $10,385.02 fixed-price contract has a completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, is supplying these prescription medications under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which provides a wide range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not utilize a set-aside designation.

Generated 12/12/24, 9:23 AM